al Hisham Nazer

Executive Director
Cardiology
Birzeit Pharmaceuticals LTD
Palestinian Territory

Business Expert Cardiology
Biography

"Mr. Tal Hisham Nazer has been the Chief Executive Officer of Bupa Arabia since 2008. Leading this top and fast growing specialized health care company to higher standards, his relationship circle has widened and strengthened in the insurance market in Saudi Arabia with regulators, healthcare providers and the insured. Mr. Tal Nazer serves as a Board member on various companies and committees. He is a Board member of Arabian Medical Marketing Co. Ltd Nawah and the Chairman of the Saudi Arabia Monetary Agency (SAMA)’s Insurance General Committee. Mr. Tal Nazer is also a Board Member of the Human Resources Development Fund (HRDF) and a member of the Young Presidents Organization (YPO) and also the Young Global Leaders (YGL). Mr. Tal Nazer holds an MBA from The Wharton School, Pennsylvania, USA (in Finance and Buyouts, completed in 2001) and a BA in Economics from the University of California at Los Angeles (completed in 1996). ​​​​" "Mr. Tal Hisham Nazer has been the Chief Executive Officer of Bupa Arabia since 2008. Leading this top and fast growing specialized health care company to higher standards, his relationship circle has widened and strengthened in the insurance market in Saudi Arabia with regulators, healthcare providers and the insured. Mr. Tal Nazer serves as a Board member on various companies and committees. He is a Board member of Arabian Medical Marketing Co. Ltd Nawah and the Chairman of the Saudi Arabia Monetary Agency (SAMA)’s Insurance General Committee. Mr. Tal Nazer is also a Board Member of the Human Resources Development Fund (HRDF) and a member of the Young Presidents Organization (YPO) and also the Young Global Leaders (YGL). Mr. Tal Nazer holds an MBA from The Wharton School, Pennsylvania, USA (in Finance and Buyouts, completed in 2001) and a BA in Economics from the University of California at Los Angeles (completed in 1996). ​​​​"

Research Intrest

pharmaceutical Industry